Companies in #Transplant Diagnostics

CareDx, Inc. is a molecular diagnostics company specializing in transplant surveillance, specialty oncology, and cell therapy testing. The company's AlloSure Kidney donor-derived cell-free DNA test is the leading non-invasive transplant monitoring assay in U.S. clinical use, complemented by AlloMap Heart for heart transplant recipients and HeartCare for combined heart transplant surveillance. Following the July 2026 close of the Naveris acquisition (adding the Medicare-covered NavDx MRD blood test for HPV-positive head-and-neck and anal cancers) and the $171.2M divestiture of its global Lab Products business to Eurobio Scientific, CareDx is repositioned as a focused U.S. precision-medicine testing and digital-patient-solutions company.

Werfen is a family-owned specialized diagnostics company founded in Barcelona in 1966, providing hemostasis, acute care diagnostics, transfusion, autoimmunity and transplant testing to hospitals and laboratories in more than 100 territories. Its automated Aptiva multi-analyte system and ACL TOP hemostasis analyzers anchor a portfolio that spans instruments, reagents and lab data management software.